ACHIEVEMENT OF LDL-C GOALS IN PATIENTS AT MODERATE TO VERY HIGH CARDIOVASCULAR RISK ON LIPID-LOWERING DRUG THERAPY (CEPHEUS II)

被引：1
|
作者：
Logunova, Natalia [1 ]
Gurina, Natalia [1 ]
Boytsov, Sergey [2 ]
机构：
[1] AstraZeneca, Dept Med, Moscow, Russia
[2] Minist Hlth, State Res Ctr Prevent Med, Moscow, Russia
来源：
ATHEROSCLEROSIS | 2017年 / 263卷
关键词：
D O I：
10.1016/j.atherosclerosis.2017.06.770
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO417
引用
收藏
页码：E236 / E237
页数：2
相关论文
共 50 条
  • [41] Reaching LDL-C Targets in Patients with Moderate, High, and Very High Risk for Cardiovascular Disease After Bariatric Surgery According to Different Guidelines
    Guillermo Ponce de León-Ballesteros
    Hugo A. Sánchez-Aguilar
    Carlos A. Aguilar-Salinas
    Miguel F. Herrera
    Obesity Surgery, 2021, 31 : 2087 - 2096
  • [42] VARIABILITY OF THE LDL-C RESPONSE TO TWO INTENSIVE LIPID-LOWERING THERAPY REGIMENS IN PATIENTS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Li, Ya
    Jin, Jinhua
    Zhang, Wenbin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 151 - 151
  • [43] Are coronary patients on lipid-lowering therapy in Europe achieving the recommended LDL-C target? Results from the Dyslipidemia International Study (DYSIS) II Europe
    Gitt, A. K.
    Ferrieres, J.
    De Ferrari, G.
    Elisaf, M.
    Hermans, M. P.
    Kiernan, T.
    Oganov, R.
    Lautsch, D.
    Ashton, V.
    Ambegaonkar, B.
    EUROPEAN HEART JOURNAL, 2015, 36 : 286 - 286
  • [44] METABOLIC EFFECTS OF DIFFERENT LIPID-LOWERING THERAPY REGIMENS IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
    Koshelskaya, O.
    Sushkova, A.
    Kravtshenko, E.
    Suslova, T.
    JOURNAL OF HYPERTENSION, 2017, 35 : E193 - E194
  • [45] Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice
    Ferrieres, Jean
    Gorcyca, Katherine
    Iorga, Serban R.
    Ansell, David
    Steen, Dylan L.
    CLINICAL THERAPEUTICS, 2018, 40 (09) : 1484 - 1495
  • [46] Cardiovascular risk factors and use of lipid-lowering therapy in a cohort of HIV-positive patients with high cardiovascular risk
    Denman, Johanna
    Manavi, Kaveh
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [47] LDL-C Reduction With Lipid-Lowering Therapy for Primary Prevention of Major Vascular Events Among Older Individuals
    Andersson, Niklas Worm
    Corn, Giulia
    Dohlmann, Tine Lovso
    Melbye, Mads
    Wohlfahrt, Jan
    Lund, Marie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (14) : 1381 - 1391
  • [48] Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients
    Egede, Rasmus
    Jensen, Lisette Okkels
    Hansen, Henrik Steen
    Antonsen, Lisbeth
    Hansen, Knud Norregaard
    Junker, Anders
    Thayssen, Per
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (03) : 376 - 379
  • [49] LDL-C Goal Attainment According to Prescribed Lipid-Lowering Therapy: Results from the LIPIDE European Survey
    Desamericq, Gaelle
    Laforest, Laurent
    Schwalm, Marie-Sophie
    Moulin, Philippe
    Michel, Emilie
    Eteve, Caroline
    Coffin, Gabriel
    Ritleng, Cecile
    Van Ganse, Eric
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S154 - S154
  • [50] Lipid-lowering therapy today: Treating the high-risk cardiovascular patient
    Berra, Kathleen
    JOURNAL OF CARDIOVASCULAR NURSING, 2008, 23 (05) : 414 - 421
12345